Gnh India Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 2018.

2018 Mumbai, Maharashtra, India Active

Last Updated: February 06, 2026

About Gnh India Pharmaceuticals Limited

Gnh India Pharmaceuticals Limited, a active public limited company, was established on 11 May 2018 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51909MH2018PLC309277. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹25.00 Cr and a paid-up capital of ₹10.16 Cr.

Its leadership includes Vinesh Deepak Mestry (Director), Savithav Nair (Director), Harshal Suresh Parmar (Director). Past directors included Utsav Milan Shah, Savithav Nair, Harshal Suresh Parmar. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Unit No. 14, 15, 16, 17, Ground Floor, Prabhadevi Industrial Estate,, Enterprises Industrial Premises, 408, Veer Sawarkar Road, Prabhadevi, Mumbai, Maharashtra, 400025.

Company Details

CIN/LLPIN
U51909MH2018PLC309277
Registration Number
309277
Incorporation Date
11 May 2018
Authorized Capital
₹25.00 Cr
Paid-Up Capital
₹10.16 Cr
ROC Code
Roc Mumbai
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 25.00 Cr as on 06-02-2026
Paid Up Capital ₹ 10.16 Cr as on 06-02-2026
Company Age 7 Year, 9 Months
Last Filing with ROC 31 Mar 2025
Revenue Growth **** 43.81% (FY 2023)
Profit Growth **** 38.51% (FY 2023)
Ebitda **** -23.89% (FY 2023)
Net Worth 46.31% (FY 2023)
Total Assets **** 74.38% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Gnh India Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Gnh India Pharmaceuticals Limited?

Current Directors

Name	Designation	Appointment Date	Status
Vinesh Deepak Mestry	Director	22 Sep 2023	Current
Savithav Nair	Director	17 Aug 2024	Current
Harshal Suresh Parmar	Director	17 Aug 2024	Current
Jessica Piyush Gupta	Whole-Time Director	11 May 2018	Current
Piyush Ashok Gupta	Managing Director	11 May 2018	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	31 Jul 2024	Past
Pramod Abcsdd	Director Appointed In Casual Vacancy	29 Sep 2024	Past
Pramod Abcsdd	Additional Director	29 Sep 2024	Past
Pramod Abcsdd	Cfo	-	Past
Pramod Abcsdd	Director	31 Jul 2024	Past
Pramod Abcsdd	Director	14 Sep 2023	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Gnh India Pharmaceuticals.

Gnh India Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 43.81% increase. The company also saw a substantial improvement in profitability, with a 38.51% increase in profit. The company's net worth Soared by an impressive increase of 46.31%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

43.81%

*******

Revenue from Operations

*******

43.36%

*******

Total Assets

*******

74.38%

*******

Profit or Loss

*******

38.51%

*******

Net Worth

*******

46.31%

*******

EBITDA

*******

-23.89%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Gnh India Pharmaceuticals?

In 2023, Gnh India Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Gnh India Pharmaceuticals?

Unlock and access historical data on people associated with Gnh India Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Gnh India Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gnh India Pharmaceuticals's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Gnh India Pharmaceuticals

Recent Activity within the Organization

Director Appointment

The activity Meenu Rathor was appointed as a Company Secretary was appointed as a Company Secretary on 27 Oct 2025 & has been associated with this company since 3 months 21 days . was completed.
27 Oct 2025
Annual General Meeting

The activity Gnh India Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
30 Sep 2025
Director Appointment

Khyati Milind Joshi was appointed as a Cfo was appointed as a Cfo on 25 Jul 2025 & has been associated with this company since 6 months 24 days . was recorded as a recent event.
25 Jul 2025
Balance Sheet

Progress on Gnh India Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
31 Mar 2025
Director Appointment

Progress on Tanzeelah Mohammed Irfan Shaikh was appointed as a Company Secretary was appointed as a Company Secretary on 03 Sep 2024 & has been associated with this company since 1 year 5 months . was documented.
03 Sep 2024
Director Appointment

Aditya Bhawarlal Prajapati was appointed as a Cfo was appointed as a Cfo on 03 Sep 2024 & has been associated with this company since 1 year 5 months . was recorded as a recent event.
03 Sep 2024

Explore recent activity and updates - View Recent Activity